P53, bcl-2 and Ki-67 in the diagnosis of insular thyroid gland cancer: Case report with a review of literature;P53, bcl-2 i Ki-67 u dijagnostici inzularnog karcinoma š titnjače: Prikaz bolesnika s pregledom literature

Lijecnicki Vjesnik

Volumn 128, Issue 9-10, 2006, Pages 264-267

  Novosel, Irena ^a   Bulimbašić, Stela ^b   Ramljak, Vesna ^c   Matković, Božica ^d   Došen, Danijel ^c   Šeparović, Viktor ^c  

^a Op a Bolnica Dr Ivo Pedi i   (Croatia)

^b Croatian Academy of Medical Sciences   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d Pfizer HCP Corporation   (Croatia)

Author keywords

Carcinoma diagnosis, pathology; Ki 67 antigen analysis; Proto oncogene proteins C bcl 2 analysis; Thyroid neoplasms diagnosis, pathology; Tumor suppressor protein p53 analysis

Indexed keywords

CALCITONIN; CD34 ANTIGEN; CYTOKERATIN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; THYROGLOBULIN; THYROID TRANSCRIPTION FACTOR 1;

AGED; ANAPLASTIC CARCINOMA; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CASE REPORT; CLINICAL EXAMINATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULAR THYROID GLAND CANCER; PROGNOSIS; REVIEW; STRIDOR; THYROID CANCER; THYROID MASS; THYROIDECTOMY;

AGED; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33750593050     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Chan JKC. Tumors of thyroid and parathyroid glands. U: Fletcher CDM, ur. Diagnostic Histopathology of Tumors. 1. izd. London: Churchill Livingstone; 2000, str. 997-1000.
2. Pilotti S, Collini P, Mariani L i sur. Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 1997;21:1466-1473.
3. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (»insular«) thyroid carcinoma. A reinterpretation of Langhans' »wuchernde Struma«. Am J Surg Pathol 1984;8:655-668.
4. Rosai H. Rosai and Ackermann's Surgical Pathology. 9. izd. Toronto: Mosby; 2004, str. 549-52.
5. Jain R, Chaturvedi KU, Khurana N, Aggarwal AK. Insular carcinoma of thyroid - a case report. Indian J Pathol Microbiol 2004 47;420-3.
6. Albores-Saavedra J, Carrick K. Where to set the treshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol 2004;15:297-305.
7. Soares P, Trovisco V, Rocha A i sur. BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Arch 2004;6:572-6.
8. Papotti M, Botto Micca F, Favero A, Palestini N, Bussolati G. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 1993;17:291-301.
9. Justin EP, Seabol JE, Robinson RA, Walker WP, Gurll NJ, Hawes DR. Insular carcinoma. A distinct thyroid carcinoma with associated iodine 131 localization. J Nucl Med 1991;32:1358-136.
10. Yamashita H, Noguchi Y, Noguchi S i sur. Significance of an insular component in follicular thyroid carcinoma with distant metastasis at initial presentation. Endocr Pathol 2005;16:41-8.
11. Volante M, Cavallo GP, Papotti M. Prognosis factors of clinical interest in poorly differentiated carcinomas of the thyroid. Endocr Pathol 2004;15:313-7.
12. Dobashi Y, Sugimura H, Sakamoto A i sur. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 1993;17:375-81.
13. Holm R, Nesland JM. Retinoblastoma and p53 tumour supressor gene protein expression in carcinomas of the thyroid gland. J Pathol 1994;172:267-272.
14. Soares P, Cameselle-Teijeiro J, Sobrinho-Simoes M. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 1994;24:205-210.
15. Pilotti S, Collini P, Del Bo R, Cattoretti G, Pierotti MA, Rilke F. A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland. Am J Surg Pathol 1994;18:1054-1064.
16. Tallini G, Garcia-Rostan G, Herrero A i sur. Downregulation of p27KIP1 and Ki67/Mib 1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 1999;23:678-85.